UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will participate in a ...

Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today ...

TD Cowen raised its price target on Analog Devices, Inc. (NASDAQ:ADI)’s stock to $250 from the prior target of $200, while ...

Analysts at TD Cowen revealed their optimism for RTX Corporation (NYSE: RTX) on May 24, increasing the price target from $142 ...

In a note released Tuesday, Mr. Morrison warned he expect a “moderation” in the Montreal-based retailer’s sales for the ...

Josh Jennings, an analyst from TD Cowen, reiterated a Buy rating on Medtronic plc (NYSE:MDT) with an unchanged price target of $95. The analyst viewed FQ4 2025 results favourably as the company ...

On May 21, TD Cowen analyst Oliver Chen continued his cautious view on Target Corp. (NYSE:TGT) with a Hold rating. With his new earnings estimates, the analyst derived a price target of $105 ...

GLP-1 drugs like Ozempic show widespread promise beyond weight loss/diabetes, but cost and supply limit broader adoption.

TD Cowen forecasts that Nvidia’s revenue from AI chips will “more than double” from $100 billion in 2024 to $262 billion in 2030 as the market continues to expand. We are “incrementally more confident ...

Roper Technologies, Inc. (Nasdaq: ROP) announced that it is presenting at the TD Cowen 53rd Annual Technology, Media & ...

Josh Jennings, an analyst from TD Cowen, reiterated a Buy rating on Medtronic plc (NYSE:MDT) with an unchanged price target ...

It’s the first time in several years that mass brands have outpaced prestige, though the softening for high-end beauty brands ...